Exane Derivatives boosted its stake in Halliburton Company (NYSE:HAL) by 109.0% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 33,715 shares of the oilfield services company’s stock after buying an additional 17,587 shares during the period. Exane Derivatives’ holdings in Halliburton were worth $1,440,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in HAL. Israel Discount Bank of New York GFN acquired a new position in Halliburton during the fourth quarter valued at approximately $100,000. Sumitomo Mitsui Financial Group Inc. acquired a new position in Halliburton during the first quarter valued at approximately $100,000. Perigon Wealth Management LLC raised its position in Halliburton by 0.8% in the first quarter. Perigon Wealth Management LLC now owns 2,049 shares of the oilfield services company’s stock valued at $101,000 after buying an additional 17 shares during the last quarter. Ledyard National Bank raised its stake in Halliburton by 6.5% in the second quarter. Ledyard National Bank now owns 2,469 shares of the oilfield services company’s stock worth $106,000 after buying an additional 150 shares in the last quarter. Finally, Independent Portfolio Consultants Inc. raised its stake in Halliburton by 87.6% in the second quarter. Independent Portfolio Consultants Inc. now owns 2,711 shares of the oilfield services company’s stock worth $116,000 after buying an additional 1,266 shares in the last quarter. 79.67% of the stock is currently owned by institutional investors and hedge funds.
Halliburton Company (NYSE HAL) opened at 40.02 on Friday. Halliburton Company has a one year low of $40.00 and a one year high of $58.78. The stock’s 50 day moving average price is $42.63 and its 200-day moving average price is $47.79. The firm’s market capitalization is $34.88 billion.
Halliburton (NYSE:HAL) last announced its earnings results on Monday, July 24th. The oilfield services company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.18 by $0.05. Halliburton had a positive return on equity of 2.97% and a negative net margin of 0.86%. The company had revenue of $4.96 billion for the quarter, compared to analyst estimates of $4.86 billion. During the same quarter in the prior year, the company earned ($0.14) EPS. The firm’s revenue for the quarter was up 29.3% compared to the same quarter last year. On average, equities research analysts expect that Halliburton Company will post $1.12 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be given a dividend of $0.18 per share. The ex-dividend date is Friday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 1.80%. Halliburton’s payout ratio is -423.50%.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/08/12/halliburton-company-nysehal-shares-bought-by-exane-derivatives-updated-updated-updated.html.
HAL has been the subject of a number of research analyst reports. HSBC Holdings plc reaffirmed a “buy” rating and issued a $62.00 price objective (down previously from $65.00) on shares of Halliburton in a report on Thursday, June 22nd. Barclays PLC reissued an “overweight” rating on shares of Halliburton in a report on Monday, June 26th. Guggenheim downgraded shares of Halliburton from a “buy” rating to a “neutral” rating in a report on Tuesday, June 27th. Zacks Investment Research downgraded shares of Halliburton from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Finally, ValuEngine raised shares of Halliburton from a “sell” rating to a “hold” rating in a report on Saturday, July 22nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, twenty-eight have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $59.60.
In other news, Director William E. Albrecht purchased 8,000 shares of the company’s stock in a transaction that occurred on Monday, May 15th. The shares were acquired at an average cost of $46.33 per share, with a total value of $370,640.00. Following the purchase, the director now owns 8,000 shares in the company, valued at $370,640. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.46% of the stock is owned by corporate insiders.
Halliburton Company Profile
Halliburton Company provides services and products to the upstream oil and natural gas industry throughout the lifecycle of the reservoir, from locating hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completion, and optimizing production throughout the life of the field.
What are top analysts saying about Halliburton Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Halliburton Company and related companies.